Palomino Laboratories (PALX) Cash & Current Investments (2022 - 2025)

Palomino Laboratories' Cash & Current Investments history runs 4 years deep, the most recent figure standing at $8.1 million for Q4 2025.

• In Q4 2025, Cash & Current Investments rose 5931.21% year-over-year to $8.1 million; the TTM figure through Dec 2025 stood at $8.1 million (up 5931.21% YoY), while the FY2025 annual figure was $8.1 million, up 5931.21% from the prior year.
• Cash & Current Investments came in at $8.1 million for Q4 2025 at Palomino Laboratories, up from $7.9 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $8.1 million in Q4 2025 to a low of $322.0 in Q2 2024.
• A 4-year average of $1.3 million and a median of $500.0 in 2022 frame the typical range for Cash & Current Investments.
• Across the five-year window, Cash & Current Investments sank 35.6% in 2024 and jumped 2452250.62% in 2025, its largest moves.
• Palomino Laboratories' Cash & Current Investments stood at $500.0 in 2022, then slipped by 24.0% to $380.0 in 2023, then soared by 35336.05% to $134657.0 in 2024, then soared by 5931.21% to $8.1 million in 2025.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $8.1 million, $7.9 million, and $1887.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison